Factors predictive of severe Clostridium difficile infection depend on the definition used

Anaerobe

Volumn 37, Issue , 2016, Pages 43-48

  Khanafer, Nagham ^a,b   Barbut, Frédéric ^c,d   Eckert, Catherine ^c,d   Perraud, Michel ^a   Demont, Clarisse ^e   Luxemburger, Christine ^e   Vanhems, Philippe ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e SANOFI PASTEUR   (France)

Author keywords

CDI; Clostridium difficile; Definition; Infection; Risk factors; Severe Clostridium difficile infection; Severity

Indexed keywords

CREATININE; LACTATE DEHYDROGENASE; SERUM ALBUMIN; ALBUMINOID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRANCE; HUMAN; INTESTINE PERFORATION; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGACOLON; MORTALITY; NEUTROPHIL COUNT; PRIORITY JOURNAL; SEPTIC SHOCK; SEX DIFFERENCE; CLOSTRIDIUM INFECTION; DIARRHEA; FOLLOW UP; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NOMENCLATURE; PATHOPHYSIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROSPECTIVE STUDY;

AGED; ALBUMINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; DIARRHEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TERMINOLOGY AS TOPIC;

EID: 84956960728     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.08.002     Document Type: Article

References (29)

1. Surawicz C.M., Brandt L.J., Binion D.G., Ananthakrishnan A.N., Curry S.R., Gilligan P.H., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 2013, 108(4):478-498. quiz 99.
2. Nanwa N., Kendzerska T., Krahn M., Kwong J.C., Daneman N., Witteman W., et al. The economic impact of Clostridium difficile infection: a systematic review. Am. J. Gastroenterol. 2015, 110(4):511-519. 10.1038/ajg.2015.48.
3. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 2002, 346(5):334-339.
4. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 2005, 26(3):273-280. 10.1086/502539.
5. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173(9):1037-1042. 10.1503/cmaj.050978.
6. Barbut F., Jones G., Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr. Opin. Infect. Dis. 2011, 24(4):370-376. 10.1097/QCO.0b013e32834748e5.
7. Rodriguez-Pardo D., Almirante B., Bartolome R.M., Pomar V., Mirelis B., Navarro F., et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J. Clin. Microbiol. 2013, 51(5):1465-1473.
8. Kim J., Kang J.O., Kim H., Seo M.R., Choi T.Y., Pai H., et al. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin. Microbiol. Infect. 2013, 19(6):521-527. 10.1128/JCM.03352-12.
9. Mascart G., Delmee M., Van Broeck J., Cytryn E., Karmali R., Cherifi S. Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 1435-4373. 10.1007/s10096-013-1864-2.
10. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann. Intern Med. 2006, 145(10):758-764.
11. Debast S.B., Bauer M.P., Kuijper E.J. Committee. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20(Suppl. 2):1-26. 10.1111/1469-0691.12418.
12. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010, 31(5):431-455.
13. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin. Microbiol. Infect. 2009, 15(12):1067-1079. 10.1111/j.1469-0691.2009.03099.x.
14. Institut de Veille Sanitaire Conduite à tenir: diagnostic, investigation, surveillance, et principes de prévention et de maîtrise des infections à Clostridium difficile 2006, http://www.invs.sante.fr/publications/2006/guide_raisin/index.html.
15. Starzengruber P., Segagni Lusignani L., Wrba T., Mitteregger D., Indra A., Graninger W., et al. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin. Wochenschr 2014, 126(13-14):427-430. 10.1007/s00508-014-0549-x.
16. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005, 353(23):2442-2449. 10.1056/NEJMoa051639.
17. Henrich T.J., Krakower D., Bitton A., Yokoe D.S. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg. Infect. Dis. 2009, 15(3):415-422. 10.3201/eid1503.080312.
18. Shivashankar R., Khanna S., Kammer P.P., Harmsen W.S., Zinsmeister A.R., Baddour L.M., et al. Clinical factors associated with development of severe-complicated Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 2013, 11(11):1466-1471. 10.1016/j.cgh.2013.04.050.
19. Aguirre de Cárcer D., Cuiv P.O., Wang T., Kang S., Worthley D., Whitehall V., Gordon I., McSweeney C., Leggett B., Morrison M. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J. 2011, 5(5):801-809. 10.1038/ismej.2010.177.
20. Kyne L., Sougioultzis S., McFarland L.V., Kelly C.P. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect. Control Hosp. Epidemiol. 2002, 23(11):653-659. 10.1086/501989.
21. Bibbo S., Lopetuso L.R., Ianiro G., Di Rienzo T., Gasbarrini A., Cammarota G. Role of microbiota and innate immunity in recurrent Clostridium difficile infection. J. Immunol. Res. 2014, 2014:462740. 10.1155/2014/462740.
22. Bauer M.P., Hensgens M.P., Miller M.A., Gerding D.N., Wilcox M.H., Dale A.P., et al. Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clin. Infect. Dis. 2012, 55(Suppl. 2):S149-S153. 10.1093/cid/cis340.
23. Wilcox M.H., Shetty N., Fawley W.N., Shemko M., Coen P., Birtles A., et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin. Infect. Dis. 2012, 55(8):1056-1063. 10.1093/cid/cis614.
24. Walk S.T., Micic D., Jain R., Lo E.S., Trivedi I., Liu E.W., et al. Clostridium difficile ribotype does not predict severe infection. Clin. Infect. Dis. 2012, 55(12):1661-1668. 10.1093/cid/cis786.
25. McDonald L.C. Virulence and clinical outcomes in Clostridium difficile infection: a complex business. Clin. Infect. Dis. 2013, 56(6):906-907. 10.1093/cid/cis1001.
26. Madan R., Jr W.A. Immune responses to Clostridium difficile infection. Trends Mol. Med. 2012, 18(11):658-666. 10.1016/j.molmed.2012.09.005.
27. Islam J., Taylor A.L., Rao K., Huffnagle G., Young V.B., Rajkumar C., et al. The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study. Anaerobe 2014, 27:82-86. 10.1016/j.anaerobe.2014.03.011.
28. Fujitani S., George W.L., Murthy A.R. Comparison of clinical severity score indices for Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 2011, 32(3):220-228. 10.1086/658336.
29. Abou Chakra C.N., Pepin J., Valiquette L. Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS One 2012, 7(1):e30258. 10.1371/journal.pone.0030258.